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Abstract
Expression of two Epstein-Barr virus (EBV) immediate-early gene products, Zta (encoded by the BZLF1 gene) and Rta (encoded by the
BRLF1 gene), are required for the switch from latent infection to virus replication. We have analyzed the regions of the BRLF1 gene
promoter (Rp) that are required for Rta and Zta transactivation of Rp. Notably, significant synergy between the actions of Rta and Zta on
Rp was observed in both a B cell line (DG75) and an epithelial cell line (293), suggesting that during induction of the viral lytic cycle low
levels of these viral transactivators are likely sufficient to initiate the entire lytic cascade. However, while two Zta binding sites (ZREs) have
been identified in Rp, the proximal ZRE was the dominant site for mediating Zta transactivation. Rta activation of Rp was diminished by
mutation of the proximal Sp1 binding site, as previously reported (J. Virol. 75 (2001), 5240), but mutation of this site only had a modest
impact on transactivation of Rp by Rta in the presence of Zta. Further deletion analyses of Rp failed to identify a critical site for Rta
transactivation of Rp in the presence of Zta, with the exception of deleting the TATAA box of Rp, suggesting that a non-DNA binding
mechanism may be involved in the observed activation of Rp by Rta. We also observed promiscuous activation of several reporter constructs
by Rta, suggesting that Rta activation of gene expression may involve a general non-DNA binding mechanism. Decreasing the amount of
transfected Rta expression vector reduced background Rta activation, while retaining specific activation of Rp.
© 2003 Elsevier Science (USA). All rights reserved.
Introduction
Epstein-Barr virus (EBV) is a lymphotropic human her-
pesvirus that latently infects B lymphocytes, resulting in a
concomitant growth transformation of the infected cell. In-
fection is closely associated with several human cancers,
including nasopharyngeal carcinoma and African Burkitt’s
lymphoma, and also plays a role in several lymphoprolif-
erative diseases in immunocompromised individuals. In
vitro the transforming potential of EBV is evidenced by its
ability to immortalize B lymphocytes. Immortalization is
achieved through the expression of a relatively small subset
of EBV-encoded genes that serve to establish and maintain
cellular transformation.
Propagation of EBV from host to host is dependent on
the activation of an estimated 80–100 viral genes, culmi-
nating in the production of infectious virions. While these
genes remain quiescent during latency, a switch in the
genetic program leading to the expression of viral replica-
tion associated genes can be accomplished in vitro by treat-
ment of latently infected B lymphocytes with various re-
agents, including phorbol esters, butyrate, Ca2 ionophores,
and anti-immunoglobulin (Bauer et al., 1982; Faggioni et
al., 1986; Kallin et al., 1979; Luka et al., 1979; Tovey et al.,
1978; Zur et al., 1978). Activation of the lytic cascade by
crosslinking surface immunoglobulin or superinfection re-
sults initially in the expression of two viral genes, BZLF1
and BRLF1, which exhibit similar induction kinetics (max-
imal mRNA levels are reached between 2 and 4 h postin-
duction) (Biggin et al., 1987; Flemington et al., 1991;
Takada and Ono, 1989). Both the BZLF1 gene product (Zta;
also referred to as ZEBRA and EB1) and the BRLF1 gene
product (Rta) have been shown to be transcriptional activa-
tors (reviewed in Speck et al., 1997). Expression of Zta and
* Corresponding author. Fax: 1-404-727-7768.
E-mail address: sspeck@rmy.emory.edu (S.H. Speck).
R
Available online at www.sciencedirect.com
Virology 310 (2003) 199–206 www.elsevier.com/locate/yviro
0042-6822/03/$ – see front matter © 2003 Elsevier Science (USA). All rights reserved.
doi:10.1016/S0042-6822(03)00145-4
Rta leads to the activation of early genes and ultimately
virus replication.
Zta is a sequence-specific transcriptional activator, dis-
tantly related to c-fos (Farrell et al., 1989), which binds
DNA via degenerate AP-1 and CREB-like binding sites
(Farrell et al., 1989; Flemington and Speck, 1990a, 1990b;
Urier et al., 1989). Zta homodimerizes through a leucine
zipper motif at the carboxy terminus of the protein (Flem-
ington and Speck, 1990c; Kouzarides et al., 1991) and is
able to autoactivate its own expression through binding to
two adjacent sites within Zp (ZIIIA and ZIIIB sites) (Flem-
ington and Speck, 1990a). Rta has also been shown to
specifically bind a GC-rich motif (Gruffat et al., 1990, 1992;
Gruffat and Sergeant, 1994); however, it also appears that
Rta activation of some promoters occurs through a mecha-
nism that does not involve direct DNA binding (Gutsch et
al., 1994; Ragoczy and Miller, 2001). DNA binding-depen-
dent and independent mechanisms of gene activation have
also been noted for the Rta homologs encoded by other
gamma herpesviruses (Song et al., 2002, 2001; Deng et al.,
2002a, 2000b, Zhang et al., 1998; Liang et al., 2002; Lukac
et al., 2001).
Several cis elements involved in regulating Rp activity
have been identified (Fig. 1). These include sites for binding
the cellular transcription factors NF1, Sp1, YY1, and Zif, as
well as two binding sites for Zta (ZRE-1 and ZRE-2)
(Zalani et al., 1992, 1995, 1997; Glaser et al., 1998;
Ragoczy and Miller, 2001) (Fig. 1). A recent analysis of Rta
transactivation of Rp, in the context of an EBV latently
infected B cell line, has implicated the Sp1 sites in mediat-
ing Rta autoactivation of Rp (Ragoczy and Miller, 2001).
He we assess Rta and Zta transactivation of Rp in the
absence of EBV infection and hence other viral factors. We
also show here that unlike Zp, Rp is only weakly responsive
to the lytic cycle inducers TPA and ionomycin. The latter
result is consistent with the hypothesis that transcription of
the BZLF1 gene, and subsequent expression of Zta, pre-
cedes transcription of the BRLF1 gene (Flemington et al.,
1991; Speck et al., 1997).
Results
Rp is weakly responsive to the combination of phorbol
ester and calcium ionophore
Because the EBV lytic cycle can be induced in many
latently infected B cell lines by the addition of TPA, in the
presence or the absence of calcium ionophore, we assessed
whether Rp was responsive to phorbol ester and calcium
Fig. 1. (A) Schematic illustrations of known and postulated cis elements within the BRLF1 gene promoter (Rp) and the sequences contained in various
Rp-driven luciferase reporter constructs;1 refers to the site of transcription initiation. RI and RII are domains with homology the ZI and ZII domains present
in the BZLF1 gene promoter, respectively. (B) Nucleotide sequence of Rp depicting the locations of specific cis elements and indicating mutations introduced
into these putative regulatory sequences. Also shown is the location of the splice donor site for the first exon of the BRLF1 transcript.
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ionophore (Fig. 2). Rp promoter fragments of various
lengths, fused to the firefly luciferase gene (see schematic in
Fig. 1A), were transiently transfected into the EBV-negative
Burkitt’s lymphoma (BL) cell line DG75. As a positive
control, the BZLF1 promoter (Zp) fragment from 221 to
12 bp (221ZpLuc) was also introduced into the DG75
cell line. All Rp-driven luciferase reporter constructs, as
well as221ZpLuc, exhibited very low basal level activity.
However, while the 221ZpLuc reporter construct was
strongly induced by the addition of TPA and ionomycin (
200-fold induction), the Rp-driven luciferase reporter con-
structs were only weakly responsive to TPA and ionomycin
(Fig. 2). This is consistent with previous data indicating that
phorbol ester induction of the lytic cycle predominantly
targets activation of BZLF1 gene transcription, followed by
Zta induction of Rp (Flemington et al., 1991).
Synergistic activation of Rp by Rta and Zta
To assess autoactivation of Rp by the EBV immediate-
early transactivators Rta and Zta, Rp-driven luciferase re-
porter constructs were transiently transfected into the DG75
BL cell line either alone or in conjunction with an Rta
expression vector, a Zta expression vector, or both (Fig. 3).
In the DG75 EBV-negative BL cell line all the Rp-driven
luciferase reporter constructs assayed were responsive to
Rta and Zta and also strongly transactivated by the addi-
tional of both transactivators (Fig. 3A). Deletion of Rp
sequences from324 to 110 bp did not have a significant
impact on Rta or Zta transactivation of Rp, nor the observed
synergistic transactivation by Rta and Zta together (Fig.
3A).
Because Rta has been shown to disrupt latency in some
EBV-infected epithelial cell lines (Zalani et al., 1996;
Ragoczy et al., 1998), we assessed Zta and Rta transactiva-
tion of Rp in the 293 epithelial cell line (Fig. 3B). Notably,
Zta alone only weakly transactivated Rp in this cell line,
while Rta alone strongly activated all the Rp-driven reporter
constructs examined (Fig. 3B). However, even though Zta
activation was weak, strong synergistic transactivation was
observed when both Rta and Zta were present (Fig. 3B). In
addition, deletion of Rp sequences from 324 to 253 bp
resulted in an threefold reduction in Rta and Rta/Zta
transactivation of Rp. Further deletion of sequences to
110 bp partially restored the levels of Rta and Rta/Zta
transactivation of Rp. A similar pattern was observed in the
DG75 cell line, although the effect was much smaller (
twofold) (see Fig. 3A). Importantly, in both the DG75 and
293 cell lines all the necessary cis elements for Rta and Zta
transactivation of Rp were present in the promoter fragmentFig. 2. Induction of Zp- and Rp-driven reporter constructs by a combina-
tion of phorbol ester and calcium ionophore (ionomycin). The structure of
the Rp-driven reporter constructs is shown in Fig. 1. TPA was added to a
final concentration of 20 ng/ml and ionomycin as added to a 1 M final
concentration. Data were compiled from five independent experiments and
the standard error of the mean is shown.
Fig. 3. Activation of Rp-driven reporter constructs by Rta and Zta. Reporter
constructs were transfected into either the DG75 Burkitt’s lymphoma cell
line (A) or the 293 epithelial cell line (B), as described under Materials and
Methods; 2 g of Zta expression vector (pSV40-BZLF1) and/or 2 g of
Rta expression vector (pMH48) was cotransfected with the Rp-driven
reporter plasmids, as indicated. Data are represented as the fold induction
in luciferase activity relative to that of the Rp-driven reporter constructs in
the absence of either Zta or Rta. Data were compiled from at least two
independent experiments and the standard error of the mean is shown.
201P. Liu, S.H. Speck / Virology 310 (2003) 199–206
containing the region from 110 to 56 bp relative to the
site of transcription initiation.
Rta promiscuously activates transcription from reporter
plasmids
In the course of optimizing Rta and Zta transactivation of
Rp-driven reporter constructs, we noted that Rta could
transactivate the parent luciferase reporter construct
(pGL2Luc) lacking any Rp sequences (Fig. 4). Although the
fold induction of pGL2Luc was substantially below the fold
induction of the Rp-driven reporter constructs (see Figs. 5A
and B), this observation raised the concern that Rta trans-
activation of the vector might confound the analysis of Rta
activation of Rp. Furthermore, Rta transactivation was not
limited to the pGL2Luc reporter construct, but was also
observed with several other reporter constructs (data not
shown). In addition, we also noted a low, but measurable,
level of Zta transactivation of the pGL2Luc construct. No-
tably, there was little or no observed synergistic transacti-
vation of the pGL2Luc vector by Rta and Zta (Fig. 5A),
while Rta and Zta strongly synergized to activate Rp
(324RpLuc) (see Figs. 4 and 5B). To avoid the concerns
raised by Zta and Rta transactivation of the vector, we
titrated the amount of Zta and Rta expression vectors trans-
fected (Fig. 5). Reducing the amount of Zta expression
vector transfected to 100 ng completely eliminated any
detectable transactivation of the parent reporter construct
(data not shown), while retaining the ability to potently
synergize with Rta (see Figs. 5 B and C). The amount of Rta
expression vector transfected was titrated from 0.5 ng to 1
g, alone and in conjunction with 100 ng of Zta expression
vector, and transactivation of both the pGL2Luc and
324RpLuc reporter constructs was determined (Fig. 5).
There was a parallel reduction in the fold induction by Rta
of the pGL2Luc and 324RpLuc reporter constructs. To
eliminate detectable Rta transactivation of the pGL2Luc
parent reporter construct required reducing the amount of
transfected Rta expression vector to5.0 ng (Fig. 5A). This
amount of Rta expression vector only weakly activated the
324RpLuc reporter construct (Fig. 5C). However, in con-
junction with 100 ng of Zta expression vector (which alone
only transactivates the 324RpLuc construct 10-fold; see
Fig. 6), low levels of Rta expression vector were still able to
potently synergize with Zta to activate Rp (Fig. 5C).
The proximal Zta binding site is the dominant site for Zta
transactivation of Rp
To assess the role of known and putative cis elements in
the regulation of Rp by Rta and Zta, a panel of site-directed
mutant Rp reporter constructs was generated (see Figs. 1B
and 6). With respect to Zta transactivation of Rp, mutation
of the proximal Zta binding site (ZRE1) eliminated detect-
able Zta transactivation of Rp and also the ability of Zta to
synergize with Rta in the transactivation of Rp (Fig. 6; see
324RpZRE1). In contrast, mutation of the distal Zta
binding site (324RpZRE2) had little impact on either
Zta transactivation of Rp or Zta/Rta synergistic transactiva-
tion of Rp (Fig. 6; see 324RpZRE2). Mutation of other
cis elements within Rp had little or no impact on Zta
transactivation of Rp (Fig. 6). It should be noted that nearly
identical results were obtained when higher levels (2 g) of
Rta and Zta expression vectors were transfected into the
DG75 EBV-negative BL cell line or the 293 epithelial cell
line (data not shown), although, as shown in Fig. 5, the fold
inductions were overall substantially higher. This indicates
that decreasing the amount of Rta and Zta expression plas-
mid trasfected did not alter the specificity of Zta and Rta
activation of Rp and that there was no observed differences
in the requirements for Zta activation of Rp in B cells and
epithelial cells. Thus, the proximal ZRE appears to be the
critical site for Zta activation of Rp in both B cells and
epithelial cells.
The proximal Sp1 site is critical for Rta activation of Rp,
but not for synergistic activation of Rp by Rta and Zta
With respect to Rta transactivation of Rp, mutation of the
proximal Sp1 site (324RpSp1-p) greatly diminished Rta
transactivation of Rp in the DG75 cell line (Fig. 6; see
inset). In contrast, mutation of the distal Sp1 site
(324RpSp1-d) had little or no impact on Rta activation
of Rp (Fig. 6; see inset). Notably, mutation of the proximal
Sp1 site had only a slight impact on synergistic activation of
Rp by Rta in conjunction with Zta (Fig. 6). The latter result
Fig. 4. Comparison of Zta and Rta activation of the empty pGL2Luc
(Promega) parent reporter plasmid to the 324RpLuc reporter construct.
DG75 cells were transfected and analyzed as described under Materials and
Methods. Data are depicted as activity relative to the pGL2Luc reporter
construct in the absence of either Zta or Rta expression. Data were com-
piled from three independent experiments and the standard error of the
mean is shown.
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raises the possibility that Rta transactivation of Rp requires
the cooperation of an Rp-bound factor and that Zta binding
to the ZRE1 site in Rp can, at least partially, substitute for
the role of Sp1 binding to the proximal Sp1 site. Thus, the
proximal Sp1 binding sites appears to play an important role
in Rta activation of Rp in the absence of Zta. None of the
other cis elements examined were critical for Rta transac-
tivation of Rp (Fig. 6; see inset).
Deletion of Rp sequences from 30 to 10 bp ablates
Rta transactivation of Rp
In an attempt to systematically map sequences within Rp
that mediate Rta transactivation, several 20-bp internal de-
Fig. 5. Impact of titrating the amount of transfected Rta expression plas-
mid, in the absence (Rta) and the presence (Zta/Rta) of cotransfection with
100 ng of the Zta expression, on activation of the pGL2Luc parent reporter
vector (A) and the 324RpLuc reporter construct (B). C shows an ex-
panded graph of Rta and Rta plus Zta activation of the pGL2Luc and
324RpLuc reporter plasmids. Fold induction for pGL2Luc and
324RpLuc is expressed relative to that of the pGL2Luc and 324RpLuc
reporter plasmids in the absence of either Rta or Zta expression,
respectively. Data were compiled from three independent experiments and
the standard error of the mean is shown.
Fig. 6. Rta and Zta transactivation of mutant Rp-driven reporter constructs.
Transfection of DG75 cells with 2 g of the indicated reporter constructs
alone or with the Zta expression plasmid (100 ng) and/or the Rta expres-
sion plasmid (1 ng), as indicated. The inset shows on an expanded scale the
basal activities of the reporter constructs, as well as the fold activation by
Zta and Rta alone. Fold induction represents the fold activation relative to
that of the wild-type 324RpLuc reporter construct in the absence of Rta
and Zta (defined as 1.0). Data were compiled from at least three indepen-
dent experiments and the standard error of the mean is shown.
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letions were generated in the context of the 110RpLuc
reporter construct (see Materials and Methods). These de-
letions were transiently transfected into the DG75 BL cell
line along with the Rta and Zta expression vectors, as
described above. No sequences within the region from
110 to 50 bp of Rp appeared critical for Rta transacti-
vation of Rp (Fig. 7; see 110Rp110/90, 110Rp90/
70, and 110Rp70/50). Deletion of sequences from
50 to 30 bp, which removes the proximal Sp1 (Sp1-p)
and Zta (ZRE1) binding sites, eliminated Zta activation of
Rp (Fig. 7). Consistent with the loss of Zta and Rta activa-
tion upon deletion of the sequences from50 to30 bp, no
synergistic induction of the 110Rp(50/30) by Rta in
conjunction with Zta was observed (Fig. 7). Furthermore,
deletion of the region containing the Rp TATAA box
[110Rp(30/10)] completely abrogated detectable
transactivation of Rp by Zta and Rta (alone and together)
(Fig. 7).
Discussion
Both Rta and Zta are essential for EBV replication
(Feederle et al., 2000), and independently each transactiva-
tor has been shown capable of triggering virus reactivation
from latency (Countryman et al., 1987; Countryman and
Miller, 1985; Zalani et al., 1996; Ragoczy et al., 1998). A
number of studies have demonstrated responsiveness of Zp
to stimuli that trigger virus reactivation from latency (Flem-
ington and Speck, 1990d; Countryman et al., 1987; Coun-
tryman and Miller, 1985; Schwarzmann et al., 1994; Mon-
talvo et al., 1991), indicating that initial induction of the
virus lytic cycle likely involves direct activation of BZLF1
gene transcription. However, it is less clear whether these
reactivation stimuli also directly activate Rp or whether
induction of Rp is dependent on activation of Zp followed
by expression of Zta and subsequent activation of Rp. Here
we examined the responsiveness of Rp to two known in-
ducers of the EBV lytic cycle, phorbol ester and calcium
ionophore, and demonstrated that Rp is only weakly respon-
sive to these stimuli compared to Zp (see Fig. 2). This is
consistent with the hypothesis that reactivation signals may
preferentially target Zp.
While Rp responded weakly to induction by phorbol
ester and calcium ionophore, it was very responsive to
induction by Zta and Rta. Zta activation of Rp was shown to
predominantly occur through the proximal ZRE site (ZRE-
1), while Rta activation of Rp did not clearly map to a single
site. Indeed, the only mutation that ablated detectable Rta
activation involved deleting the Rp TATA box. Consistent
with a previous report (Ragoczy and Miller, 2001), mutation
of the proximal Sp1 binding site reduced, but did not elim-
inate, Rta activation of Rp. However, the inhibition of Rta
activation of Rp by mutating the proximal Sp1 site did not
affect the overall synergistic induction of Rp by Rta and Zta.
The latter suggests that Zta binding to ZRE-1 may func-
tionally compensate for the loss of Sp1 binding to the
proximal Sp1 site in Rta activation of Rp. In addition, unlike
the results of Ragoczy and Miller (2001), we did not ob-
serve any contribution of the distal Sp1 site to Rta activation
of Rp in either 293 or DG75 cells. An important distinction
between the studies reported here and those of Ragoczy and
Miller (2001) is that the latter studies were carried out in the
context of a latent EBV infection (HH514-16 Burkitt’s
lymphoma cell line). Thus, the impact of specific mutations
in Rp on Rta activation in this context could refect indirect
actions of Rta (e.g., through induction of other viral genes
that may participate in regulating transcription from Rp). In
addition, it is of note that Ragoczy and Miller (2001) failed
to observe any impact of mutating the Zta binding sites in
Rp on Rta activation. This suggests that Rta does not induce
significant expression of Zta in HH514-16 cells, a conclu-
sion that is supported by a previous study (Ragoczy et al.,
1998).
Although Rta has been shown to be a sequence-specific
DNA binding protein, Rta responsive promoters (including
Fig. 7. Rta and Zta transactivation of Rp deletion mutants. Transfection of
DG75 cells with 2 g of the indicated reporter constructs alone or cotrans-
fected with the Zta expression plasmid (100 ng) and/or the Rta expression
plasmid (1 ng), as indicated. The inset shown on an expanded scale the
basal activities of the reporter constructs, as well as the fold activation by
Zta and Rta alone. Fold induction represents the fold activation relative to
that of the undeleted 100RpLuc reporter construct in the absence of Rta
and Zta (defined as 1.0). Data were compiled from four independent
experiments and the standard error of the mean is shown.
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Rp) have been identified that lack obvious Rta binding sites
(Ragoczy and Miller, 2001; Gutsch et al., 1994). This also
appears to be true for the KSHV Rta homolog, which has
been shown to activate promoters through either direct
DNA binding (Lukac et al., 2001; Deng et al., 2002b; Song
et al., 2002, 2001) or through interaction with specific cel-
lular factors (e.g., Sp1 and RBP-Jk/CBF-1) (Liang et al.,
2002; Zhang et al., 1998). This suggests that a basic prop-
erty of Rta homologs may be their ability to interact with a
number of cellular transcription factors to facilitate gene
activation, as well as targeting genes through direct DNA
binding. Why the Rta homologs exhibit this dual function-
ality remains unclear.
Materials and methods
Cell culture, transfections, and reporter gene assays
The EBV-negative Burkitt’s lymphoma B cell line DG75
was grown at 37°C in RPMI 1640 medium supplemented
with 10% heat-inactivated fetal calf serum, 100 U of peni-
cillin, and 100 mg of streptomycin per milliliter. DG75 cells
were transfected using DEAE–dextran/DMSO shock, as
previously described (Liu et al., 1997). Briefly, 107 cells per
transfection were washed once with phosphate-buffered sa-
line (PBS), and the cell pellet was resuspended in 0.5 ml of
RPMI 1640 medium without serum. Cells were added to 0.5
ml of RPMI 1640 medium with DEAE–dextran (1 mg/ml),
2 g of reporter plasmid DNA, and the indicated amount of
Rta and/or Zta expression plasmid (refer to individual fig-
ures). After incubation at room temperature for 30 min, cells
were subjected to DMSO shock (addition of 0.5 ml of 20%
DMSO for 2 min). Following washing with PBS, cells were
resuspended in 10 ml of RPMI 1640 with 10% serum and
cultured at 37°C in a 5% CO2 incubator. For induction by
TPA, ionomycin, or both, the final concentrations of re-
agents were TPA at 20 ng/ml and 1 M. ionomycin.
The 293 cell line (available from ATCC) was originally
established by transforming human embryonic kidney epi-
thelium with adenovirus DNA (Graham et al., 1977). 293
cells were cultured in Iscove’s modified Dulbecco’s me-
dium with 10% fetal calf serum, glutamine, and penicillin/
streptomycin. The 293 cell line was transfected using Su-
perfect (Qiagen) according to the manufacturer’s protocol.
Transfected cells were harvested 48–72 h posttransfec-
tion and washed once in PBS. Firefly luciferase activity was
determined by resuspended transfected cells in cell lysis
buffer and the assay was performed according to the man-
ufacturer’s protocol (Promega). The luciferase activities of
reporter constructs were standardized to the parent unin-
duced wild-type reporter construct, which was set at a value
of 1.0. Thus, the activities were expressed as a fold-induc-
tion relative to those of the uninduced wild-type reporter
construct.
Plasmids
The 221ZpLuc construct was generated from the
221ZpCAT plasmid (Flemington and Speck, 1990d) and
was generated as described by Liu et al., (1997). The Rp-
driven luciferase (RpLuc) reporter constructs were gener-
ated by PCR amplification, using the EBV BamHI R frag-
ment as a template, and cloned into the pGL2Luc reporter
plasmid (Promega). All RpLuc reporter constructs con-
tained sequences to 56 bp relative to the site of transcrip-
tion initiation (see Fig. 1). Mutations in Rp were introduced
by PCR-based mutagenesis and incorporated a diagnostic
restriction endonuclease cleavage site (see Fig. 1B).
The sequences of the mutated promoters was confirmed by
DNA sequencing. For those Rp reporter constructs con-
taining mutations in specific cis elements, diagnostic restric-
tion endonuclease cleavage sites were introduced as
follows: an XbaI site was introduced into the 321Rp
Sp1-p, 321RpSp1-d, 321RpZif, and 321Rp YY1
mutant reporter constructs; a BamHI site was introduced
in 321RpZRE1; an EcoRI site was introduced in
321RpZRE2; an XbaI site was introduced in321RpRI;
and a SacI site was introduced into321RpRII (summarized
in Fig. 1B). For all the 110RpLuc deletion constructs, an
XbaI site was created at the junction of the internal deletions.
The Zta expression vector (pSV40-BZLF1), containing the
BZLF1 gene under the control of the SV40 early promoter and
enhancer, was constructed as previously described (Fleming-
ton and Speck, 1990a). The Rta expression vector (pMH48),
containing the BRLF1 open reading frame under the control of
the SV40 early promoter and enhancer, was constructed as
previously described (Hardwick et al., 1988).
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